|
[Related PubMed/MEDLINE]
Total Number of Papers: 217
|
|
|
| |
|
[Display Entries]
|
|
>> all entries
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Case-control study of paternal occupational exposures and childhoodbone tumours and soft-tissue sarcomas in Great Britain, 1962-2010. |
--- |
| 2 |
2020 |
Different 18 F-FDG PET parameters for the prediction of histological response to neoadjuvant chemotherapy in pediatric Ewing sarcoma family of tumors. |
18F-FDG PET, MTV, NAC |
| 3 |
2020 |
Ewing sarcoma family of tumors-derived small extracellular vesicle proteomics identify potential clinical biomarkers. |
sEVs |
| 4 |
2020 |
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol. |
VDC/IE, VIDE |
| 5 |
2020 |
Metastasis of Ewing Sarcoma to the Pancreas: Case Report and Literature Review. |
ES |
| 6 |
2020 |
Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing Sarcoma Study 04. |
IE, PFS, VDC |
| 7 |
2020 |
Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience. |
EFS, OS |
| 8 |
2020 |
Primary Renal Ewing Sarcoma in Children and Young Adults. |
--- |
| 9 |
2020 |
[Research on Analysis of Final Diagnosis and Prognostic Factors, and Development of New Therapeutic Drugs for Malignant Tumors (Especially Malignant Pediatric Tumors)]. |
--- |
| 10 |
2019 |
Ewing's sarcoma of the lung: A rare case. |
CT, PET, PNET |
| 11 |
2019 |
Extra-skeletal Ewing Sarcoma of the chest wall in a child. |
CT, ES-EWS |
| 12 |
2019 |
Prognostic profiling of the immune cell microenvironment in Ewings Sarcoma Family of Tumors. |
EFS, HIF-1alpha, OS, TME |
| 13 |
2018 |
Clinicopathologic Features of the Non-CNS Primary Ewing Sarcoma Family of Tumors in the Head and Neck Region. |
FLI-1 |
| 14 |
2018 |
Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT). |
IHC, OS, PFS |
| 15 |
2018 |
Interinstitutional patient transfers between rapid chemotherapy cycles were feasible to utilize proton beam therapy for pediatric Ewing sarcoma family of tumors. |
PBT, VDC-IE |
| 16 |
2018 |
Loss of MTAP expression is a negative prognostic marker in Ewing sarcoma family of tumors. |
MTAP, OS |
| 17 |
2018 |
NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing's sarcoma family of tumors: a case report. |
NUT |
| 18 |
2017 |
A Comparison of Pediatric vs. Adult Patients with the Ewing Sarcoma Family of Tumors. |
OS, PNET, RT |
| 19 |
2017 |
Ewing sarcoma family of tumors in children younger than 10 years of age. |
OS, RFS |
| 20 |
2017 |
Haploidentical hematopoietic cell transplantation for disseminated Ewing sarcoma. |
GVHD |
| 21 |
2017 |
Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors. |
IHC |
| 22 |
2017 |
Initial FDG-PET/CT predicts survival in adults Ewing sarcoma family of tumors. |
MTV, OS, PFS, TLG |
| 23 |
2017 |
Outcomes of Adults With Ewing Sarcoma Family of Tumors (ESFT) of the Kidney: A Single-Institution Experience. |
--- |
| 24 |
2017 |
Rare adrenal gland incidentaloma: an unusual Ewing's sarcoma family of tumor presentation and literature review. |
CT |
| 25 |
2017 |
Systemic Therapy Outcomes in Adult Patients with Ewing Sarcoma Family of Tumors. |
--- |
| 26 |
2016 |
Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases. |
IHC, SRCS, SRCT |
| 27 |
2016 |
Ewing sarcoma and the new emerging Ewing-like sarcomas: (CIC and BCOR-rearranged-sarcomas). A systematic review. |
ELS |
| 28 |
2016 |
Initial diagnostic management of pediatric bone tumors. |
OS |
| 29 |
2016 |
Investigational therapies for Ewing sarcoma: a search without a clear finding. |
ES, mTOR, PARP, VEGF |
| 30 |
2016 |
Management of Ewing sarcoma family of tumors: Current scenario and unmet need. |
--- |
| 31 |
2016 |
Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report. |
VAC/IE |
| 32 |
2016 |
Multimodality Treatment in Ewing's Sarcoma Family Tumors of the Maxilla and Maxillary Sinus: Review of the Literature. |
PNETs |
| 33 |
2016 |
Outcomes of 50 Patients With Ewing Sarcoma Family of Tumors Treated at a Single Institution in Taiwan. |
OS, PFS |
| 34 |
2016 |
Pediatric Malignant Bone Tumors: A Review and Update on Current Challenges, and Emerging Drug Targets. |
OS |
| 35 |
2016 |
Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group. |
CI, EFS, IE, LC, OS, VDC, VTc |
| 36 |
2016 |
Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor. |
OS, PFS |
| 37 |
2016 |
Synthetic treatment of intracranial peripheral primitive neuroectodermal tumor with multiple metastasis: a case report. |
ES, pPNET |
| 38 |
2016 |
The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas. |
SCO |
| 39 |
2015 |
A Case of Renal Primitive Neuroectodermal Tumor Confirmed by Fluorescence in situ Hybridization. |
PNET |
| 40 |
2015 |
Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol. |
--- |
| 41 |
2015 |
Histological diversity and clinical characteristics of Ewing sarcoma family of tumors in children: A series from a tertiary care center in South India. |
FISH, PNET |
| 42 |
2015 |
Late recurrence of a tumor of Ewing's sarcoma family of tumors: report of a case. |
EWS, PNET |
| 43 |
2015 |
Medication Exposures and Subsequent Development of Ewing Sarcoma: A Review of FDA Adverse Event Reports. |
FAERS |
| 44 |
2015 |
Prognostic factors in head and neck Ewing sarcoma family of tumors. |
EFS, NACT, OS, WBC |
| 45 |
2015 |
Role of Radiotherapy in the Multimodal Treatment of Ewing Sarcoma Family Tumors. |
LC, OS, RT |
| 46 |
2015 |
Targeted therapies for advanced Ewing sarcoma family of tumors. |
--- |
| 47 |
2015 |
[Combined therapy for children and adolescents with Ewing tumors (a 25-year experience)]. |
--- |
| 48 |
2014 |
A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma: a genetically distinct variant of Ewing-like sarcoma. |
SRCSs |
| 49 |
2014 |
A study of docetaxel and irinotecan in children and young adults with recurrent or refractory Ewing sarcoma family of tumors. |
CR, DI, ORR, PFS, PRs |
| 50 |
2014 |
Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol. |
EFS, LCR, NACT |
| 51 |
2014 |
Immunoreactivity using anti-ERG monoclonal antibodies in sarcomas is influenced by clone selection. |
MRT |
| 52 |
2014 |
Lower extremity reconstruction after limb-sparing sarcoma resection of the proximal tibia in the pediatric population: case series, with algorithm. |
LSS, OS |
| 53 |
2014 |
Phosphoproteomic profiling reveals IL6-mediated paracrine signaling within the Ewing sarcoma family of tumors. |
--- |
| 54 |
2014 |
Proliferation index: a continuous model to predict prognosis in patients with tumours of the Ewing's sarcoma family. |
AI, OS, PI, RFS |
| 55 |
2014 |
Survival and prognostic factors in adult patients with recurrent or refractory ewing sarcoma family tumours: a 13-years retrospective study in Turkey. |
ICE, IE |
| 56 |
2014 |
Synthesis and structure-activity relationship studies of small molecule disruptors of EWS-FLI1 interactions in Ewing's sarcoma. |
--- |
| 57 |
2014 |
Targeting cancer stem-like cells as an approach to defeating cellular heterogeneity in Ewing sarcoma. |
CSC |
| 58 |
2014 |
The GANT61, a GLI inhibitor, induces caspase-independent apoptosis of SK-N-LO cells. |
GLI1, PI |
| 59 |
2013 |
Adult primary pulmonary primitive neuroectodermal tumor: molecular features and translational opportunities. |
PNET |
| 60 |
2013 |
DNA methylation profile distinguishes clear cell sarcoma of the kidney from other pediatric renal tumors. |
CCSK, CMN, NK, RTK |
| 61 |
2013 |
Efficacy of carbon-ion radiotherapy and high-dose chemotherapy for patients with unresectable Ewing's sarcoma family of tumors. |
CIRT, HDC |
| 62 |
2013 |
Ewing sarcoma of the bone in children under 6 years of age. |
AIEOP, OS, PFS |
| 63 |
2013 |
Ewing's sarcoma with an uncommon clinical course: A case report. |
--- |
| 64 |
2013 |
Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo. |
NB, RMS |
| 65 |
2013 |
Intensity-modulated radiation therapy with dose-painting for pediatric sarcomas with pulmonary metastases. |
RMS, WLI |
| 66 |
2013 |
Latent adrenal Ewing sarcoma family of tumors: A case report. |
--- |
| 67 |
2013 |
Optimal management of Ewing sarcoma family of tumors: recent developments in systemic therapy. |
IGF, mTOR, PARP |
| 68 |
2013 |
Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma. |
--- |
| 69 |
2013 |
Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology. |
--- |
| 70 |
2013 |
Role of extracorporeal irradiation in malignant bone tumors. |
ECI, MBT, MSTS, OS |
| 71 |
2013 |
Superficial small round-cell tumors with special reference to the Ewing's sarcoma family of tumors and the spectrum of differential diagnosis. |
--- |
| 72 |
2012 |
A Novel Role of IGF1 in Apo2L/TRAIL-Mediated Apoptosis of Ewing Tumor Cells. |
Apo2L, Cer, CerS, IGF-1, IGF1R, XIAP |
| 73 |
2012 |
A TARBP2-dependent miRNA expression profile underlies cancer stem cell properties and provides candidate therapeutic reagents in Ewing sarcoma. |
CSC, miRNAs |
| 74 |
2012 |
Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience. |
EFS, SJCRH |
| 75 |
2012 |
Diagnostic accuracy of ⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis. |
CI, FDG, PET, PET/CT, ROC |
| 76 |
2012 |
Ewing's sarcoma family of tumors originating in the main bronchus. |
PNET |
| 77 |
2012 |
EWS-FLI-1-targeted cytotoxic T-cell killing of multiple tumor types belonging to the Ewing sarcoma family of tumors. |
CTL |
| 78 |
2012 |
Human leukocyte antigen distribution in German Caucasians with advanced Ewing's sarcoma. |
HLA |
| 79 |
2012 |
PARP-1 inhibition as a targeted strategy to treat Ewing's sarcoma. |
--- |
| 80 |
2012 |
Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma. |
ARMS, NPT, PCa |
| 81 |
2012 |
PRAS40 is a functionally critical target for EWS repression in Ewing sarcoma. |
EWS |
| 82 |
2012 |
Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection. |
chNKG2D, NKG2DLs |
| 83 |
2012 |
Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas. |
allo-HSCT, OS |
| 84 |
2012 |
STAT3 Regulates Proliferation and Immunogenicity of the Ewing Family of Tumors In Vitro. |
STAT3 |
| 85 |
2011 |
A to Z of extraskeletal Ewing sarcoma family of tumors in adults: imaging features of primary disease, metastatic patterns, and treatment responses. |
--- |
| 86 |
2011 |
Assessment of Chemotherapy Response Using FDG-PET in Pediatric Bone Tumors: A Single Institution Experience. |
OS, PET, SUV2 |
| 87 |
2011 |
Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's sarcoma family of tumors. |
OS |
| 88 |
2011 |
Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer. |
--- |
| 89 |
2011 |
Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: implications for tumor biology and therapy. |
AIF, DPPs, FAP, NPY, Y5Rs |
| 90 |
2011 |
Epithelial marker expression does not rule out a diagnosis of Ewing's sarcoma family of tumours. |
CEA, CK, EMA |
| 91 |
2011 |
Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group. |
--- |
| 92 |
2011 |
Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma. |
--- |
| 93 |
2011 |
Heterogeneous role of the glutathione antioxidant system in modulating the response of ESFT to fenretinide in normoxia and hypoxia. |
--- |
| 94 |
2011 |
Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development. |
miRNA, MSC |
| 95 |
2011 |
Modeling initiation of Ewing sarcoma in human neural crest cells. |
hNC-MSC, hNCSC, MSC |
| 96 |
2011 |
Morphometric analysis of DNA ploidy and nuclear cell cycle regulators in Ewing's sarcoma/primitive neuroectodermal tumor. |
SRCTs |
| 97 |
2011 |
Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma. |
--- |
| 98 |
2011 |
Pathobiologic markers of the ewing sarcoma family of tumors: state of the art and prediction of behaviour. |
--- |
| 99 |
2011 |
Potential role of FDG PET imaging in predicting metastatic potential and assessment of therapeutic response to neoadjuvant chemotherapy in Ewing sarcoma family of tumors. |
NACT |
| 100 |
2011 |
Prognostic significance of HLA class I expression in Ewing's sarcoma family of tumors. |
HLA, mAb |
|
A Search Service for Abbreviation / Long Form
